NanoViricides
NNVC
#10093
Rank
โ‚น2.31 B
Marketcap
โ‚น107.37
Share price
-4.00%
Change (1 day)
-17.53%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น52.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น54.58. In 2024 the company made an earnings per share (EPS) of -โ‚น62.63 an increase over its 2023 EPS that were of -โ‚น66.21.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น52.14-16.75%
2024-โ‚น62.63-5.41%
2023-โ‚น66.215.71%
2022-โ‚น62.63-13.58%
2021-โ‚น72.48-66.11%
2020-โ‚น213.851.7%
2019-โ‚น210.27-10.98%
2018-โ‚น236.22-22.35%
2017-โ‚น304.22-10.53%
2016-โ‚น340.01375%
2015-โ‚น71.58-85.19%
2014-โ‚น483.1742.11%
2013-โ‚น340.0126.67%
2012-โ‚น268.43-6.25%
2011-โ‚น286.3214.28%
2010-โ‚น250.53100%
2009-โ‚น125.27-0%
2008-โ‚น125.27-33.33%
2007-โ‚น187.90-0%
2006-โ‚น187.904445.07%
2005-โ‚น4.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚น4.47-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น189.69-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น583.38-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น265.74-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น679.46-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น321.75-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK